Ductal carcinoma in situ, or DCIS, is a precursor lesion to invasive breast cancer; however, not all DCIS becomes invasive cancer. Given our inability to accurately determine which DCIS lesions will progress, current clinical management consists of surgical resection for everyone with the possible additions of radiation and endocrine therapy. Multiple clinical trials and leaders in the field of breast surgical oncology are challenging our assumptions about the uniform approach to DCIS and are attempting to design treatment based on biology— tune in to hear about the evolving approach to management of DCIS! Hosts: Alexa Glencer, MD Michael Alvarado, MD Rita Mukhtar, MD Laura Esserman, MD Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out other breast surgery episodes here: https://behindtheknife.org/podcast-category/breast/

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related